Skip to main content

Advertisement

Log in

The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Introduction

The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to be a predictor for intravenous immunoglobulin (IVIG) resistance in patients with Kawasaki disease (KD) recently. The objective of the present study was to elucidate the predictive validity of this new marker in a multicenter study.

Materials and methods

We retrospectively reviewed the clinical records of 520 consecutive KD patients (development data set) and 332 subsequent patients (validation data set) at 7 hospitals in Japan.

Results

Both NLR and PLR were significantly higher in the IVIG-resistant group than in the IVIG-responsive group. When we set the cut-off point as NLR ≥ 4.11 and PLR ≥ 119, multiple logistic regression analyses showed that a high NLR and PLR before initial IVIG were independent predictors of IVIG resistance, and their combination was a stronger predictor than either alone. The sensitivity and specificity of the combination of NLR ≥ 4.11 and PLR ≥ 119 were 0.58 and 0.73 in the development data set. Validated using an independent data set, they were 0.54 and 0.72 in the validation data set. On comparing the AUC of this predictor with those of the Gunma and Kurume scores, the AUC was highest for this predictor, followed by the Gunma score and Kurume score (0.70, 0.68, and 0.64, respectively).

Discussion

The predictive validity of the combination of a high NLR and PLR, which is a simple and convenient indicator, was equal to or better than that of the existing scoring systems. The new predictive marker may be a suitable indicator for predicting IVIG resistance in KD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

KD:

Kawasaki disease

IVIG:

Intravenous immunoglobulin

CAL:

Coronary artery lesions

NLR:

Neutrophil-to-lymphocyte ratio

PLR:

Platelet-to-lymphocyte ratio

ROC:

Receiver operating characteristic

AUC:

Area under the curve

CI:

Confidence interval

OR:

Odds ratio

References

  1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276

    CAS  PubMed  Google Scholar 

  2. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639

    Article  CAS  PubMed  Google Scholar 

  3. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 22:216–221

    Article  PubMed  PubMed Central  Google Scholar 

  4. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240

    Article  CAS  PubMed  Google Scholar 

  5. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612

    Article  PubMed  Google Scholar 

  6. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137

    Article  CAS  PubMed  Google Scholar 

  7. Sato S, Kawashima H, Kashiwagi Y, Hoshika A (2013) Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis 16:168–172

    Article  CAS  PubMed  Google Scholar 

  8. Wakiguchi H, Hasegawa S, Suzuki Y, Kudo K, Ichiyama T (2015) Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease. Pediatr Res 77:536–540

    Article  CAS  PubMed  Google Scholar 

  9. Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, Atz AM, Printz BF, Baker A, Vetter VL, Newburger JW, Pediatric Heart Network I (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158:831 e3–835 e3

    Article  Google Scholar 

  10. Acet H, Ertas F, Akil MA, Ozyurtlu F, Polat N, Bilik MZ, Aydin M, Oylumlu M, Yuksel M, Yildiz A, Kaya H, Akyuz A, Ozbek M (2016) Relationship between hematologic indices and global registry of acute coronary events risk score in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost 22:60–68

    Article  PubMed  Google Scholar 

  11. Lian L, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR, Wu MY, Chen K, Tao M, Li W (2015) Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomark 15:899–907

    Article  CAS  PubMed  Google Scholar 

  12. Maeda D, Kanzaki Y, Sakane K, Ito T, Sohmiya K, Hoshiga M (2020) Prognostic impact of a novel index of nutrition and inflammation for patients with acute decompensated heart failure. Heart Vessel. https://doi.org/10.1007/s00380-020-01590-4

    Article  Google Scholar 

  13. Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S (2016) The combined usefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease. J Pediatr 178(281–284):e1

    Google Scholar 

  14. Takeshita S, Kanai T, Kawamura Y, Yoshida Y, Nonoyama S (2017) A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease. PLoS ONE 12:e0176957

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kanai T, Ishiwata T, Kobayashi T, Sato H, Takizawa M, Kawamura Y, Tsujimoto H, Nakatani K, Ishibashi N, Nishiyama M, Hatai Y, Asano Y, Kobayashi T, Takeshita S, Nonoyama S (2011) Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective study. Circulation 124:2822–2828

    Article  CAS  PubMed  Google Scholar 

  16. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K, Kawasaki Disease Research C (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232–234

    Article  PubMed  Google Scholar 

  17. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845

    Article  CAS  PubMed  Google Scholar 

  18. Kanda Y (2013) Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48:452–458

    Article  CAS  PubMed  Google Scholar 

  19. Tang Y, Yan W, Sun L, Huang J, Qian W, Ding Y, Lv H (2016) Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol 35:2771–2776

    Article  PubMed  Google Scholar 

  20. Ha KS, Lee J, Jang GY, Lee J, Lee KC, Son CS, Lee JW (2015) Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol 116:301–306

    Article  PubMed  Google Scholar 

  21. Yuan YD, Sun J, Li PF, Wei CL, Yu YH (2017) Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease. Chin J Contemp Pediatr 19:410–413

    Google Scholar 

  22. Cho HJ, Bak SY, Kim SY, Yoo R, Baek HS, Yang S, Hwang IT, Ban JE (2017) High neutrophil: lymphocyte ratio is associated with refractory Kawasaki disease. Pediatr Int 59:669–674

    Article  CAS  PubMed  Google Scholar 

  23. Niwa Y, Sohmiya K (1984) Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. J Pediatr 104:56–60

    Article  CAS  PubMed  Google Scholar 

  24. Takeshita S, Nakatani K, Kawase H, Seki S, Yamamoto M, Sekine I, Yoshioka S (1999) The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. J Infect Dis 179:508–512

    Article  CAS  PubMed  Google Scholar 

  25. Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D, Lafferty J (2010) Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 106:470–476

    Article  PubMed  Google Scholar 

  26. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW, Investigators C (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440–1445

    Article  CAS  PubMed  Google Scholar 

  27. Hansen PR (1995) Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91:1872–1885

    Article  CAS  PubMed  Google Scholar 

  28. Mehta J, Dinerman J, Mehta P, Saldeen TG, Lawson D, Donnelly WH, Wallin R (1989) Neutrophil function in ischemic heart disease. Circulation 79:549–556

    Article  CAS  PubMed  Google Scholar 

  29. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP (1997) Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiolo 79:812–814

    Article  CAS  Google Scholar 

  30. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ (1998) Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97:19–22

    Article  CAS  PubMed  Google Scholar 

  31. Zahorec R (2001) Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14

    CAS  PubMed  Google Scholar 

  32. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW (1998) A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81:1116–1120

    Article  CAS  PubMed  Google Scholar 

  33. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, Martin DD, Newburger JW, Burns JC (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117–121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Levin M, Holland PC, Nokes TJ, Novelli V, Mola M, Levinsky RJ, Dillon MJ, Barratt TM, Marshall WC (1985) Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J (Clin Res Ed) 290:1456–1460

    Article  CAS  Google Scholar 

  35. Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D, Eguchi T, Maruyama I, Kawano Y (2010) Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. Br J Haematol 148:285–292

    Article  CAS  PubMed  Google Scholar 

  36. Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K (2014) Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. Circ J 78:188–193

    Article  CAS  PubMed  Google Scholar 

  37. Tuttle HA, Davis-Gorman G, Goldman S, Copeland JG, McDonagh PF (2003) Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc Diabetol 2:12

    Article  PubMed  PubMed Central  Google Scholar 

  38. Furie B, Furie BC (1997) Leukocyte crosstalk at the vascular wall. Thromb Haemost 78:306–309

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all investigators and their staff for their contributions to this study at the following institutions: Department of Pediatrics, Koshigaya Municipal Hospital, Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital, Department of Pediatric Cardiology, Chutoen General Medical Center, Department of Pediatrics, Hamamatsu University School of Medicine, Department of Pediatrics, National Hospital Organization, Nishisaitama-Chuo National Hospital, Department of Pediatrics, University of Toyama, Department of Pediatrics, Seirei Sakura Citizen Hospital, Department of Pediatrics, National Defense Medical College.

Funding

This work was supported in part by grants from Scientific Research (KAKENHI, 16K10082), the Japan Kawasaki Disease Research Center, the Kawasaki Disease Research from Japan Blood Products Organization, and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Kanai.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanai, T., Takeshita, S., Kawamura, Y. et al. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study. Heart Vessels 35, 1463–1472 (2020). https://doi.org/10.1007/s00380-020-01622-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-020-01622-z

Keywords

Navigation